arrow_back Trending Legislation
Share share

Study on Efficacy of Federal Drug Surveillance Systems in the US

This act mandates a study on the effectiveness of federal drug surveillance systems in the United States. The goal is to assess their ability to provide up-to-date information on illicit drug use and how this data is used to combat the drug problem. The study's findings will help improve government actions in public health and safety, potentially leading to better support for individuals affected by drug addiction.
Key points
Mandates a study on the efficacy of federal drug surveillance systems, including DOSE, SUDORS, NDEWS, and DAWN.
The study report will include findings, conclusions, and recommendations for improving these systems, including interagency communication and data collection.
Aims to enhance understanding of the drug problem in the US and improve government responses.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Curbing Illicit Drug Threats Act
Print number: HR 6045
Sponsor: Rep. Caraveo, Yadira [D-CO-8]
Process start date: 2023-10-25
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Study on Efficacy of Federal Drug Surveillance Systems in the US

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 6045.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-10-25.

What are the main provisions?

Key points include:

  • Mandates a study on the efficacy of federal drug surveillance systems, including DOSE, SUDORS, NDEWS, and DAWN.
  • The study report will include findings, conclusions, and recommendations for improving these systems, including interagency communication and data collection.
  • Aims to enhance understanding of the drug problem in the US and improve government responses.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Caraveo, Yadira [D-CO-8].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

Analysis and Potential Impact of HR 6045

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health Security